Opko Health (OPK) Non Operating Investment Income (2010 - 2026)
Opko Health (OPK) reported Non Operating Investment Income of -$298000.0 for Q1 2026, down 9.16% on a YoY basis from -$328040.3 in Q1 2025, and down 122.39% quarter-over-quarter from -$134000.0 in Q4 2025.
Opko Health (OPK) Non Operating Investment Income (2010 - 2026) Analysis & Trends
Opko Health has reported Non Operating Investment Income for 17 years, with the latest figure at -$298000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Investment Income fell 9.16% year-over-year to -$298000.0; the trailing twelve-month figure through Mar 2026 stood at -$454000.0 (up 98.28% YoY), and the FY2025 full-year result was -$429000.0, up 98.36% from the prior year.
- Non Operating Investment Income for Q1 2026 stood at -$298000.0, down from -$134000.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $446000.0 in Q3 2022, with the low at -$26.2 million in Q1 2024.
- Historically, Non Operating Investment Income has averaged -$1.7 million across 5 years, with a median of -$2000.0 in 2022.
- Annual changes were most pronounced in 2023 — Non Operating Investment Income soared 1700.0% — and 2025, when it sank 3700.0%.
- Opko Health's Non Operating Investment Income stood at -$3000.0 in 2022, then soared by 1700.0% to $48000.0 in 2023, then plunged by 102.08% to -$1000.0 in 2024, then plunged by 13300.0% to -$134000.0 in 2025, then slumped by 122.39% to -$298000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$298000.0 (Q1 2026), -$134000.0 (Q4 2025), and -$38000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | - |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | - |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Opko Health | 1.10 Bn | 754.70 Mn | 45.76 Mn | -298,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -298,000.00 |
| Mar 31, 2026 | -298,000.00 |
| Dec 31, 2025 | -134,000.00 |
| Dec 31, 2025 | -134,000.00 |
| Sep 30, 2025 | -38,000.00 |
| Sep 30, 2025 | -38,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -26.16 Mn |
| Mar 31, 2024 | -26.16 Mn |
| Dec 31, 2023 | 48,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 88,000.00 |
| Sep 30, 2023 | 88,000.00 |